title: Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation.
authors.affiliation: Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Gonda 4-130 (VM), 200 First St. SW, Rochester, MN, 55905, USA, Ketha.Siva@mayo.edu.
authors.forename: Siva S
authors.initials: SS
authors.lastname: Ketha
authors.forename: Rajiv K
authors.initials: RK
authors.lastname: Pruthi
authors.forename: Robert D
authors.initials: RD
authors.lastname: McBane
authors.forename: Waldemar E
authors.initials: WE
authors.lastname: Wysokinski
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000493:pharmacokinetics; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000601:surgery; D008991:Monitoring, Physiologic; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D014859:Warfarin / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D000925:Anticoagulants; D016682:Lupus Coagulation Inhibitor; D014859:Warfarin